Hepatocellular Carcinoma Program

Hepatocellular Carcinoma Program

UMass Memorial offers the region’s only multidisciplinary Hepatocellular Carcinoma (HCC) Program for patients with primary liver cancer. The HCC Program treats patients with cancer while they wait for a transplant. It’s one of only a handful of such programs in the Northeast.

Until recently, patients with HCC had few options for treatment or cure because their cancer is not often diagnosed until it has progressed considerably. Only 10 to 20 percent of tumors can be removed completely with surgery. Today, liver transplant is the best treatment option for appropriately selected patients with HCC.

Drawing on the expertise of the UMass Memorial Cancer Center of Excellence and UMass Memorial specialists, the HCC Program integrates the following subspecialties:

  • Medical oncology
  • Transplant hepatology
  • Surgical oncology
  • Transplant surgery
  • Interventional radiology
  • Radiology
  • Radiation oncology
  • Psychiatry
  • Social work

HCC is most commonly encountered in patients with cirrhosis, which can result from Hepatitis B or C, alcohol abuse, autoimmune diseases of the liver, chronic inflammation of the liver and hemochromatosis.